Moreover, as a special HDAC6 inhibitor, Tubastatin A (TST) can affect cell growth and promote structural modifications in cancer cells and parasites, which are potential anti-Toxoplasma gondii chemotherapeutics (51, 52). Here, HDAC6 is linked to cancer.